3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
13
Carcinoma, Non-Small-Cell Lung
12
Neoplasms
6
Rectal Neoplasms
5
Neoplasm Metastasis
5
Mouth Neoplasms
5
Lung Neoplasms
5
Head and Neck Neoplasms
5
Colonic Neoplasms
5
Pancreatic Neoplasms
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma
3
Thyroid Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Urologic Neoplasms
1
Solid Tumors
1
Soft Tissue Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Neurofibromatosis 1
1
Interventions
enzalutamide
21
Magnetic Resonance Spectroscopy
21
apalutamide
17
Androgen Antagonists
14
Specimen Handling
13
Prednisone
13
Abiraterone Acetate
13
abiraterone
9
Docetaxel
9
Radiotherapy
8
Biopsy
8
darolutamide
7
Radiosurgery
7
Pluvicto
7
Nivolumab
7
cabazitaxel
6
Lutetium-177
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
Lutetium
5
radium Ra 223 dichloride
4
pembrolizumab
4
niraparib
4
gallium 68 PSMA-11
4
cabozantinib
4
bicalutamide
4
atezolizumab
4
Watchful Waiting
4
Surveys and Questionnaires
4
Standard of Care
4
Radiotherapy, Intensity-Modulated
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Cetuximab
×
30 days
×
Clear all
No trials found.